NCT00327249
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Investigational Site 025 Little Rock, Arkansas, United States
- Investigational Site 008 Houston, Texas, United States
Clinical trial condition
Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.
NCT00327249
NCT00306813
NCT00950768
Not specified
NCT00436059
NCT00798499
NCT00864552
NCT00910078
NCT00781170
Not specified
NCT00036023
Not specified
NCT00045136